Curis
CRIS
$6.59
Share price
-13.29%
Change (1 day)
572.45%
Change (1 year)
Categories
EPS for Curis (CRIS)
EPS in 2023 (TTM): -$0.50
According to Curis's latest financial reports the company's current EPS (TTM) is -$0.50. In 2022 the company made an earnings per share (EPS) of -$0.61 a decrease over its 2021 EPS that were of -$0.50.
EPS history for Curis from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.50 | -18.03% |
| 2022 | -$0.61 | 22% |
| 2021 | -$0.50 | -25.37% |
| 2020 | -$0.67 | -30.93% |
| 2019 | -$0.97 | -2.02% |
| 2018 | -$0.99 | -44.69% |
| 2017 | -$1.79 | -20.44% |
| 2016 | -$2.25 | -10% |
| 2015 | -$2.50 | 138.1% |
| 2014 | -$1.05 | 40% |
| 2013 | -$0.75 | -25% |
| 2012 | -$1.00 | 66.67% |
| 2011 | -$0.60 | 100% |
| 2010 | -$0.30 | -60% |
| 2009 | -$0.75 | -16.67% |
| 2008 | -$0.90 | 50% |
| 2007 | -$0.60 | -33.33% |
| 2006 | -$0.90 | -41.94% |
| 2005 | -$1.55 | -8.82% |
| 2004 | -$1.70 | -5.56% |
| 2003 | -$1.80 | -86.1% |
| 2002 | -$12.95 | 0.78% |
| 2001 | -$12.85 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.82 | -864.00% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.78 | -856.00% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -$0.36 | -28.00% | 🇺🇸 USA |
 Exelixis EXEL | $0.51 | -202.00% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | 380.00% | 🇺🇸 USA |
 Cel-Sci
CVM | -$0.77 | 54.00% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$12.08 | 2,316.00% | 🇺🇸 USA |